VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 38 filers reported holding VERONA PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733,500 | -68.5% | 45,000 | -59.1% | 0.24% | -68.6% |
| Q2 2023 | $2,325,400 | -37.9% | 110,000 | -85.3% | 0.77% | -5.4% |
| Q1 2022 | $3,743,000 | -25.7% | 750,000 | 0.0% | 0.81% | -55.0% |
| Q4 2021 | $5,040,000 | +22.6% | 750,000 | 0.0% | 1.81% | +50.2% |
| Q3 2021 | $4,110,000 | -37.2% | 750,000 | -25.0% | 1.20% | -33.1% |
| Q2 2021 | $6,540,000 | -16.7% | 1,000,000 | +6.5% | 1.80% | -2.5% |
| Q1 2021 | $7,850,000 | +38.4% | 939,043 | +15.9% | 1.84% | +46.1% |
| Q4 2020 | $5,670,000 | +12.8% | 810,000 | +0.6% | 1.26% | -13.1% |
| Q3 2020 | $5,027,000 | – | 805,556 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |